Seeking Alpha

Cell Therapeutics Inc. (CTIC)

()

Instablog posts on CTIC

  • Good Stocks to Buy > Top Stocks to Invest In Right Now by top10stocks
    Good Stocks to Buy > Top Stocks to Invest In Right Now .- Success in stock trading starts by applying a wiser and REALISTIC methodology for choosing hot stocks as well as for getting in and out of them with profits in mind. In order to become a successful trader You need to look at the... More »
    November 30, 2009 • QCOM, EBAY, NVDA
  • Spectrum Pharma: The Evolution of Zevalin by Justin M. Hall
    I. Rodman & Renshaw Annual Global Investment Conference on September 10, 2009II. UBS Global Life Sciences Conference on September 23, 2009During presentations I and II, presentations were roughly the same.NOTABLEPlease with extremely broad label per FDA recommendationVery attractive... More »
    November 7, 2009 • SPPI, CTIC, CEPH
  • Spectrum Pharmaceuticals: Zevalin Has Blockbuster Potential by Justin M. Hall
    A number of positive peer-reviews evaluating Spectrum Pharmaceuticals (SPPI) radio-immunotherapy (RIT), Zevalin® were published this month. The conclusions drawn in these reviews were made from unbiased medical professionals, and indicate that the prospects for Zevalin may be... More »
    October 24, 2009 • SPPI, BYERF.PK, RHHBY.PK
  • Good morning, America by Nojus
     It’s a sunny day today, in all meanings. A sunny day today really, and DJIA tops 10 000. Maybe it’s the best new this week. Better Intel and JPMorgan earnings, I suppose. DJIA hits resistance at 9917.99 level and makes support level at 9815.   In my portfolioLGF fell down... More »
    October 15, 2009 • INTC, JPM, LGF
  • Good morning, America! by Nojus
    It’s snowing in Lithuania today, although it’s an autumn’s time. Never mind lets go up for investing ideas. Dow Jones index hits resistance level at 9917.99, but closed lower. Shorters are strong enough, but bulls are strong too. If DJIA shall not hit resistance level again,... More »
    October 14, 2009 • ENZN, CTIC, VOD
  • My stocks portfolio by Nojus
    DJIA index is in Green Zone now – it’s a bull market. But we have a strong resistance at 9917.99 point level. It’s a psychological level. If index shall retrace this level – there will be a signal for bears. If index shall hit this level - there will be a signal for bulls... More »
    October 12, 2009 • SIRI, NTWK, NDN
  • Time to earn.. by Nojus
    It’s time for quarterly companies’ earnings and revenue reports now. So we see a consolidation period in the market.  There will be good and bad results. We are waiting too and looking for trading ideas. There no important movement in DJIA yesterday – waiting mode. But... More »
    October 8, 2009 • AA, BSX, NDN
  • My portfolio by Nojus
    Stocks rallied and Dow closes up 110 points yesterday. But some of my positions closed at stop loss: ANX and CTIC. DJIA rebounds from lower trend line. I remarked about stronger buyers yesterday. It seems it’s truth. But it’s too early say about UP trend recovering:     LGF... More »
    October 6, 2009 • ANX, CTIC, LGF
  • Soligenix: The Next Cell Therapeutics Comeback Story? by Jospeh Krueger
    Soligenix, formally named Dor Biopharma, has changed their name.  But has anything else changed?  At first glance, Soligenix (OTC:SNGX) appears to be the old story of yet another fledgling biotech company, which burned through more than $100 million over 20 years and has nothing... More »
    September 26, 2009 • CTIC, SPPI
  • Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern by Justin M. Hall
    On Friday, Spectrum Pharmaceuticals (SPPI) announced the company sold $50 million worth of common shares at $7.55. As is often the case when a company sells its shares the share price falls.Shares of SPPI closed down -4.39% to $7.18 in Friday trading.As result of this most recent offering... More »
    September 18, 2009 • SPPI, ARIA, AGN

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.